England is set to become the first health system globally to offer the "Trojan horse" therapy, belantamab mafodotin (Blenrep), developed by GSK, for patients with multiple myeloma, following its ...

In the crypto market, where projects come and go with the flick of a meme or a whale’s wallet, Little Pepe ($LILPEPE) has ...